Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
361–396
Headlines
937
Sources here
23
Companies here
9
Current section United States Healthcare Plans news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Raymond James downgrades Alignment Healthcare stock rating on earnings visibility concerns

Raymond James downgraded Alignment Healthcare (NASDAQ:ALHC) to Outperform from Strong Buy and lowered its price target due to concerns about earnings visibility as the company expands into new markets. While Q2 2026 earnings beat expectations and the full-year guide was raised, increased investment spend …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -4.5% ALHC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Raymond James cuts Cigna to Outperform on lack of near-term catalysts

Raymond James downgraded Cigna Group (CI) from Strong Buy to Outperform and lowered its price target to $320 from $350, citing a lack of near-term catalysts despite an attractive valuation. The firm noted slower growth in Cigna's mature market and ongoing headwinds in its …

CI main company
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Humana’s Q2 Earnings Beat on Cash Flow. Margins Told a Different Story.

Humana's Q2 earnings showed a strong beat on revenue and adjusted EPS, with a significant surge in operating and free cash flow. However, the report also highlighted a sequential margin slide, as the company prioritizes a multi-year strategy to restore Medicare Advantage margins to …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +36.1% HUM stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Goldman Sachs Adjusts Price Target on Cigna Group to $352 From $340, Maintain Buy Rating

Goldman Sachs has increased its price target for Cigna Group (CI) to $352 from $340, while reaffirming a Buy rating on the stock. This adjustment reflects an updated outlook from the investment bank regarding the managed healthcare company. The article also notes recent analyst …

CI main company
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Bernstein raises Centene stock price target on marketplace outlook

Bernstein SocGen Group has increased its price target for Centene Corp. (NYSE: CNC) shares to $79 from $68, maintaining an Outperform rating due to positive marketplace outlook and improved earnings per share estimates. This decision follows Centene's strong second-quarter 2026 results, which surpassed expectations, …

CNC main company
Sharemaestro market context Trend signal active 52 weeks +130.9% · Next-week setup positive 60.8% CNC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Is Elevance Health (ELV) a Long-Term Winner Despite Rising Medical Costs?

Diamond Hill Capital's Q2 2026 investor letter for its Large Cap Strategy highlighted Elevance Health (ELV) as a new position, despite acknowledging pressures from rising medical costs and lower government reimbursement. The firm believes Elevance Health has positive long-term earnings potential. However, the article …

ELV main company
Sharemaestro market context Trend signal active 52 weeks +30.0% · Next-week setup positive 55.1% ELV stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Raymond James Adjusts Price Target on Cigna Group to $320 From $350, Maintain Outperform Rating

Raymond James has adjusted its price target for Cigna Group (CI) to $320, down from $350, while maintaining an Outperform rating on the stock. Cigna Group currently holds an average analyst rating of overweight and a mean price target of $342.43. The full details …

CI main company
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 6.90% Potential Upside Amidst Mixed Performance Metrics

Molina Healthcare Inc (MOH) presents a complex investment case with a potential upside of 6.90% to an average target price of $209.12. Despite serving a critical demographic in healthcare, the company faces concerns due to a 5.70% decline in revenue and a slightly negative …

MOH main company
Sharemaestro market context Trend signal active 52 weeks +17.3% MOH stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Janus Henderson Group PLC Raises Stock Holdings in Humana Inc. $HUM

Janus Henderson Group PLC increased its stake in Humana Inc. by 8.8% in the first quarter, now holding 219,065 shares valued at $38.0 million. This comes as Humana reported strong second-quarter results, exceeding revenue and adjusted EPS expectations, although its unchanged full-year guidance and …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +36.1% HUM stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Humana Inc. (NYSE:HUM) Given Consensus Recommendation of "Hold" by Brokerages

Humana Inc. (NYSE:HUM) has received a consensus "Hold" recommendation from 30 brokerages, with an average 12-month price target of $386.61. Despite exceeding second-quarter earnings expectations with adjusted EPS of $7.61 and revenue of $40.89 billion, the company's decision to maintain full-year guidance and exit …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +36.1% HUM stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Empowered Funds LLC Acquires 119,290 Shares of Healthcare Services Group, Inc. $HCSG

Empowered Funds LLC significantly increased its stake in Healthcare Services Group (HCSG) by acquiring 119,290 additional shares, bringing its total to 215,824 shares valued at $4 million. This move is part of broader institutional interest, with other hedge funds also adjusting their holdings in …

CI mentioned
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Dimensional Fund Advisors LP Purchases 62,689 Shares of Healthcare Services Group, Inc. $HCSG

Dimensional Fund Advisors LP increased its stake in Healthcare Services Group, Inc. (HCSG) by 2.7%, purchasing an additional 62,689 shares, bringing its total to 2.4 million shares valued at approximately $44.5 million. Institutional investors now own 97.97% of the company. Healthcare Services Group recently …

CI mentioned
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Sumitomo Mitsui Financial Group Revises Share Figures After Treasury Share Cancellation

Sumitomo Mitsui Financial Group has revised its share figures following a treasury share cancellation, as reported on August 3, 2026. This announcement comes amid other news for the company, including its subsidiary launching a startup pitch platform and strong first-quarter earnings with a 33% …

CI mentioned
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

CVS to now fill pet medication prescriptions

CVS Health Corp. has expanded its prescription services to include common pet medications at 9,000 of its pharmacies nationwide. Pet owners can now fill prescriptions for antibiotics, allergy treatments, flea and tick control, insulin, and pain relievers, with options for in-store pickup or delivery. …

CVS main company
Sharemaestro market context Trend signal active 52 weeks +43.0% · Next-week setup positive 57.7% CVS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Cigna: Specialty Care Profit Jumps 22% As Pharmacy Benefit Earnings Fall 27%

Cigna's second-quarter 2026 earnings showed a significant divergence between its Evernorth Health Services businesses. Specialty and Care Services saw its profit jump 22% due to strong specialty-drug growth and operational efficiencies, while Pharmacy Benefit Services experienced a 27% decline in earnings despite increased revenue, …

CI main company
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Health insurer Cigna boosts full-year earnings guidance after beating Q2 expectations

Cigna has raised its 2026 profit forecast to at least $30.45 per share, an increase of $0.10 from its previous outlook, following strong second-quarter results that surpassed analyst expectations. The improved performance was primarily driven by its Evernorth Health Services division, particularly the Specialty …

CI main company
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Molina Healthcare, Inc. (MOH) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Molina Healthcare, Inc. (MOH) securities who bought shares before February 5, 2025, and still hold them. The investigation aims to determine if Molina and its officers engaged in corporate wrongdoing. …

MOH main company
Sharemaestro market context Trend signal active 52 weeks +17.3% MOH stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Progyny Inc (PGNY) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Progyny Inc (PGNY), highlighting its current earnings forecast score of 8.55 and a "Buy" analyst rating from 11 analysts. It details the average price target of $29.50, with a high of $33.00 and a low of $26.00, …

PGNY main company CI mentioned
Sharemaestro market context Trend signal active 52 weeks +20.1% · Next-week setup negative 44.6% PGNY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Humana Inc. (HUM) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has announced an investigation into potential corporate wrongdoing by Humana Inc. (HUM). The firm is encouraging investors who purchased Humana securities prior to June 27, 2022, and still hold them, to come forward and assist with the investigation. The …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +36.1% HUM stored weekly price path from 15 Aug 2025 to 7 Aug 2026

IperionX Plans Redomiciliation to Texas, Direct Nasdaq Listing to Replace ADS Structure

IperionX plans to redomicile to Texas and pursue a direct Nasdaq listing, replacing its current American Depositary Share (ADS) structure. The company, which specializes in titanium metal and critical materials, also announced the appointment of Michael J. Loparco as an Independent Non-Executive Director. This …

CI mentioned
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

MOH5939489 Bond Profile — Key Metrics

This article provides a bond profile for Molina Healthcare, Inc. 6.25% 15-JAN-2033 (MOH5939489), detailing key metrics such as issue date, maturity date, outstanding amount, face value, and coupon rate. It identifies Molina Healthcare as a healthcare services provider with segments including Medicaid, Medicare, and …

MOH main company
Sharemaestro market context Trend signal active 52 weeks +17.3% MOH stored weekly price path from 15 Aug 2025 to 7 Aug 2026

ALHC Stock Drops As Whistleblower Probe Sparks Legal Scrutiny

Alignment Healthcare Inc. (ALHC) stock dropped significantly by 18.66% following a whistleblower lawsuit alleging the company misclassified $8–$10 million in expenses as capital expenditures to inflate Adjusted EBITDA. Several law firms have initiated investigations into potential securities law violations, posing material regulatory and governance …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -4.5% ALHC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The The Cigna Group (NYSE:CI) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Cigna Group's second-quarter results showed revenues slightly above expectations but EPS slightly below. Analysts have updated their forecasts, but there has been no major change in expectations for the business, with the consensus price target remaining largely unchanged at US$343. Despite a projected slowdown …

CI main company
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

CGHY ETF Profile: Dividends, Returns (NEO:CGHY)

This article provides a detailed profile of the CI High Yield Bond Private Pool ETF (NEO:CGHY), outlining its investment strategy, key statistics, and performance. The fund primarily invests in fixed-income securities rated BB or lower, aiming for income and long-term capital appreciation through active …

CI mentioned
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

CVS Health Corp (1CVS) Q1 2025 Earnings Report - Results, Call & Slides

CVS Health Corp (1CVS) reported strong Q1 2025 earnings, beating analyst expectations for both EPS and revenue. The company recorded an actual EPS of €1.95 against a consensus of €1.48, and actual revenue of €82.01 billion, surpassing the expected €81.20 billion. This represents a …

CVS main company
Sharemaestro market context Trend signal active 52 weeks +43.0% · Next-week setup positive 57.7% CVS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Amundi Purchases 37,501 Shares of Humana Inc. $HUM

Amundi increased its stake in Humana Inc. by 9.0% in Q1, purchasing an additional 37,501 shares to own a total of 455,385 shares valued at $78.96 million. Other institutional investors also adjusted their holdings. Humana's stock performance saw mixed sentiment with analyst upgrades and …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +36.1% HUM stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Alignment Healthcare (ALHC) and McKesson (MCK)

Analysts from Bank of America Securities have issued bullish sentiments on three healthcare companies: Stryker (SYK), Alignment Healthcare (ALHC), and McKesson (MCK). Stryker received a Buy rating with a $380.59 price target, implying a 15.3% upside. Alignment Healthcare also garnered a Buy rating and …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -4.5% ALHC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Earnings Preview: Progyny to Report Financial Results Post-market on August 06

Progyny (PGNY) is scheduled to release its financial results after the market closes on August 6th. The company is expected to report earnings of $0.05 per share, representing a 25% year-over-year increase, with revenue projected to rise 20.3% to $225.4 million. Investors will be …

PGNY main company
Sharemaestro market context Trend signal active 52 weeks +20.1% · Next-week setup negative 44.6% PGNY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

CALIDI B: Shareholders Board Members Managers and Company Profile | US3207034089

This article provides a comprehensive company profile for Calidi Biotherapeutics, Inc. (CALIDI B), including its business description as a clinical-stage immuno-oncology company. It details the company's financial data, executive committee, board of directors, and major shareholders like Armistice Capital LLC and Sabby Management LLC. …

CI mentioned
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Cigna (CI) Stock Stalls As Evernorth Carries Growth And PBM Pressure Builds

Cigna's stock experienced a slight dip despite strong Q2 2026 earnings, with adjusted EPS guidance lifted to at least US$30.45. Growth is primarily driven by its Evernorth segment, particularly specialty pharmacy and care services, which are boosting margins. However, concerns remain regarding pressure on …

CI main company
Sharemaestro market context Trend signal active 52 weeks -2.8% CI stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Elevance Health Number of Employees 2026 | Employee Count & Headcount Data

Elevance Health (ELV) had approximately 96,975 employees worldwide as of March 2026, representing an 8.8% decline since 2023. The company's workforce is primarily concentrated in the United States, India, and the Philippines, with Puerto Rico being its fastest-growing location. Elevance Health is actively hiring, …

ELV main company
Sharemaestro market context Trend signal active 52 weeks +30.0% · Next-week setup positive 55.1% ELV stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context